PLx Pharma Inc.

PLXP · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Assets
Cash & Equivalents$69,392$22,449$14,001$14,250
Short-Term Investments$0$0$0$0
Receivables$634$0$19$18
Inventory$2,458$143$0$0
Other Curr. Assets$992$393$263$597
Total Curr. Assets$73,476$22,986$14,283$14,865
Property Plant & Equip (Net)$1,088$1,553$2,085$1,394
Goodwill$2,061$2,061$2,061$2,061
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$17$17$74$68
Total NC Assets$3,166$3,631$4,219$3,523
Other Assets$0$0$0$0
Total Assets$76,642$26,617$18,503$18,388
Liabilities
Payables$10,600$863$929$653
Short-Term Debt$0$622$3,658$2,910
Tax Payable$0$0$0$0
Deferred Revenue$0$1,782$1,202$0
Other Curr. Liab.$1,279$275$305$1,170
Total Curr. Liab.$11,879$3,542$6,093$4,733
LT Debt$0$0$622$4,280
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$13,083$12,621$10,217$2,931
Total NC Liab.$13,083$12,621$10,840$7,211
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$24,962$16,164$16,933$11,944
Equity
Pref Stock$16,014$21,385$13,662$0
Common Stock$28$14$9$9
Retained Earnings-$148,274-$102,149-$86,938-$66,436
AOCI$0$0$0-$292
Other Equity$183,912$91,203$74,837$73,163
Total Equity$51,680$10,453$1,570$6,444
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$76,642$26,617$18,503$18,388
Net Debt-$69,392-$21,826-$9,721-$7,060